Evidence map›Paper›PMID 40799786›Full record

ArticleOpen forum infectious diseases2025

Efficacy of Focal Primaquine Mass Administration for Eliminating

Pyae Linn Aung, Myat Thu Soe, Than Naing Soe, Yan Zhao, Yaming Cao, Poh Poh Aung, Thit Lwin Oo, Saranath Lawpoolsri, Wang Nguitragool, Jetsumon Sattabongkot and 4 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06392152 (G6PD Deficiency Prevalence and Targeted Elimination of Residual Plasmodium Vivax Hypnozoites in Community), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06392152 naunknown statusnot on this map

G6PD Deficiency Prevalence and Targeted Elimination of Residual Plasmodium Vivax Hypnozoites in Community: Township Level Implementation in Banmauk and Moe Mauk, Myanmar

TypeinterventionalSponsorPyae Linn AungRan2019 to 2024Enrolled1,208ConditionsMalaria, Mass Drug Administration, Myanmar, Plasmodium VivaxArmsFocal Mass Drug Administration with Primaquine
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pyae Linn AungMyanmar Health Network Organization, Yangon, Myanmar.ORCID https://orcid.org/0000-0003-4635-3701
Myat Thu SoeMyanmar Health Network Organization, Yangon, Myanmar.
Than Naing SoeDepartment of Public Health, Ministry of Health, NayPyiTaw, Myanmar.
Yan ZhaoDepartment of Immunology, China Medical University, Shenyang, Liaoning Province, China.
Yaming CaoDepartment of Immunology, China Medical University, Shenyang, Liaoning Province, China.
Poh Poh AungMyanmar Health Network Organization, Yangon, Myanmar.
Thit Lwin OoMyanmar Health Network Organization, Yangon, Myanmar.
Saranath LawpoolsriDepartment of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Wang NguitragoolMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Jetsumon SattabongkotMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-3938-4588
Jaranit KaewkungwalDepartment of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Myat Phone KyawMyanmar Health Network Organization, Yangon, Myanmar.
Daniel M ParkerDepartment of Population Health and Disease Prevention, Department of Epidemiology, University of California, Irvine, California, USA.ORCID https://orcid.org/0000-0002-5352-7338
Liwang CuiDivision of Infectious Diseases and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.ORCID https://orcid.org/0000-0002-8338-1974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We conducted a cluster-randomized crossover trial to determine the effect of PQ-MDA on Results: PQ was administered in 541 participants in group 1 and 667 in group 2 during August-September 2019 and June-July 2020, respectively. In both groups, clinical Conclusions: PQ-MDA was effective in reducing both clinical and subclinical ClinicalTrialsRegistration: This study was registered with ClinicalTrials.gov (NCT06392152).

Indexed as

malariamass drug administrationMyanmarPlasmodium vivaxprimaquine

Identifiers

PMID40799786
PMCPMC12343118

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.